PATENT CLAIM ANALYSIS

Application Number: 15865695
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "259300"]

Abstract:
The invention relates to Spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide of general formula (I) which are inhibitors of phosphodiesterase 2, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

Claim (Index 16):
The method of  claim 15 , wherein\n A is selected from the group A b  consisting of wherein above mentioned groups are substituted with one R 5  and one R 6 . or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 86.0
- Lexical Diversity: 1.31915
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13951531', '14511238', '14433769', '14166012', '12084814']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8176935752365758
- 35 USC 102 Novelty (BERT): 0.5282569281497786
- Combined Prediction Score: 0.7887499105278961
- Mean Citation Score: 311.9217660000001
- Max Citation Score: 350.06256
- Similarity Product: 259.57308534447674

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test